In scientific research and laboratories, I want to
review scientific literature
The answer · Companies across the whole market
Your peers use Causaly first, then Cradle.
13 of 34 companies in this sample use Causaly. Every line links to a public source.
Which AI tools do companies use for Science & drug discovery AI? Limited beta
Your role is not listed? Describe the task you want to do.
Review scientific literature
These results show public use in this category. They do not establish use by your profession or suitability for this exact task. Your requirements have not been evaluated.
Category, industry and company size
Company size describes the employer. It does not establish access for a solo practitioner.
Science & drug discovery AI
34 companies, 4 tools
About these numbers
Counts cover companies recorded on usedby. They are not market shares. All four proof levels count. Missing size data is excluded only from size-based views. Your requirements have not been evaluated.
Companies with known size: 97%. Vendor companies excluded from this category: 0.

Causaly
13 companies
3 confirmed10 observed
Manas AI uses Causaly as its primary platform for target identification and validation in drug discovery, running evidence assessments across human genetics, preclinical, clinical, competitor and safety data before committing resources to a target.
Original source text
Manas AI uses Causaly as its primary platform for target identification and validation.
Manas AI · Read the source 
Owkin
5 companies
4 confirmed1 observed
Cleveland Clinic Abu Dhabi worked with Owkin on a proof of concept in prostate cancer, using K Pro to turn siloed, unstructured clinical data into a queryable patient registry.
Original source text
We showed concrete value: identifying patients and exploring their characteristics in seconds, while drastically reducing the time-to-insight with potential applications for tumor board meetings.
Cleveland Clinic Abu Dhabi · Read the source
















